Small-Cap REIT ETF ...
Health Care: Drugs
Celsion Corporation (CLSN: NASDAQ)
$1.01 0.07 | 7.44%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 14.99M | 20.15M | 1.14M | 6.92M |
| Receivables | 182.80K | 0.00 | 0.00 | 806.26K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 190.73K | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 23.65M | 31.51M | 2.03M | 14.12M |
| Property, Plant & Equipment, Gross | 2.04M | 1.43M | 1.43M | 1.42M |
| Accumulated Depreciation & Depletion | 924.96K | 643.47K | 1.05M | 881.28K |
| Property, Plant & Equipment, Net | 1.11M | 782.72K | 378.67K | 537.41K |
| Intangibles | 28.12K | 35.62K | 43.12K | 50.62K |
| Other Non-Current Assets | 567.19K | 322.63K | 76.80K | 97.08K |
| Total Non-Current Assets | 1.71M | 1.14M | 498.59K | 685.11K |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 25.36M | 32.65M | 2.53M | 14.81M |
| Accounts Payable | 3.17M | 5.25M | 4.55M | 2.19M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 27.23K | 0.00 | 0.00 |
| Total Current Liabilities | 5.01M | 6.15M | 6.80M | 3.75M |
| Long Term Debt | 3.66M | 71.60K | 56.40K | 179.87K |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 4.73M | 231.86K | 248.13K | 838.84K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 8.39M | 303.47K | 304.53K | 1.02M |
| Total Liabilities | 13.40M | 6.46M | 7.10M | 4.77M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 11.96M | 26.19M | -4.58M | 10.04M |
| Common Par | 379.68K | 338.99K | 140.91K | 128.95K |
| Additional Paid In Capital | 165.28M | 153.24M | 99.32M | 95.04M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -150.88M | -124.22M | -100.94M | -82.12M |
| Treasury Stock | -2.69M | -2.88M | -3.08M | -3.08M |
| Other Equity Adjustments | -126.61K | -276.70K | -18.37K | 68.17K |
| Total Capitalization | 15.62M | 26.27M | -4.52M | 10.22M |
| Total Equity | 11.96M | 26.19M | -4.58M | 10.04M |
| Total Liabilities & Stock Equity | 25.36M | 32.65M | 2.53M | 14.81M |
| Total Common Shares Outstanding | 37.30M | 33.19M | 13.33M | 12.13M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 664.92K | 712.73K | 760.27K | 760.27K |
| Basic Weighted Shares Outstanding | 34.79M | 20.92M | 12.38M | 10.66M |
| Diluted Weighted Shares Outstanding | 34.79M | 20.92M | 12.38M | 10.66M |
| Number of Employees | 19 | 19 | 16 | 19 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CLSN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- UserWatch
- UserBIO
- ContributorStocks Under-$10 Moving Hig...
- Contributor22 Biopharma Stocks With Br...
- ContributorTop 5 Small-Cap Stocks to C...
- ContributorStocks Under-$10 Moving Hig...
Latest CLSN Headlines from TheStreet
- The 5 Dumbest Things on Wall Street This Week 04.26.13 | 07:04 am
- 5 Dumbest Things on Wall Street
04.26.13 | 07:04 am - Celsion's Shameless Spin Job (Update) 04.23.13 | 05:04 pm
- Why This Fund Manager Is Short Ziopharm 03.22.13 | 07:03 am
- 4 Stocks Under $10 Spiking Higher 03.08.13 | 07:03 am
- Biotech Stock Mailbag: Northwest Bio, Amarin, Titan Pharma 02.15.13 | 06:02 am
- Ziopharm's Sarcoma Study And The Feuerstein-Ratain Rule 02.05.13 | 06:02 am
- Stocks Surge After January Jobs Report; Dow Eclipses 14,000 02.01.13 | 02:02 pm
- Biotech Stock Mailbag: Celsion, Navidea, AP Pharma, Sarepta 02.01.13 | 07:02 am
- Seeking Alpha Author Used Multiple Aliases to Tout Biotech Stocks 01.28.13 | 06:01 am
Press Releases for CLSN
- Celsion's ThermoDox® HEAT Study Findings Reviewed At The 9th Annual World Conference On Interventional Oncology (WCIO) - PR Newswire 05.17.13 | 08:05 am
- Celsion Corporation To Hold First Quarter 2013 Financial Results Conference Call On Thursday, May 9, 2013 - PR Newswire 05.01.13 | 08:05 am
- Celsion Announces ThermoDox® HEAT Study Findings To Be Reviewed At The 9th Annual World Conference On Interventional Oncology (WCIO) In New York City On May 16, 2013 - PR Newswire 05.01.13 | 08:05 am
- Celsion Corporation Provides Business Update - PR Newswire 04.23.13 | 08:04 am
- Celsion Corporation To Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013 - PR Newswire 03.12.13 | 08:03 am
- Celsion Corporation Announces $15 Million Registered Direct Offering - PR Newswire 02.22.13 | 09:02 am
- Celsion Corporation Provides An Update Regarding ThermoDox® Agreements With Zhejiang HISUN Pharmaceutical Company For China - PR Newswire 02.05.13 | 06:02 pm
- Celsion Announces Results Of Phase III HEAT Study Of ThermoDox® In Primary Liver Cancer - PR Newswire 01.31.13 | 07:01 am
- Celsion Corporation To Host Conference Call And Webcast On January 31, 2013 At 8:00 AM EST To Present Top-Line Data From Its Pivotal Phase III HEAT Study - PR Newswire 01.30.13 | 04:01 pm
- Celsion Corporation And Zhejiang Hisun Pharmaceutical Company Enter Into Technology Development Agreement For ThermoDox® For The Greater China Territory - PR Newswire 01.22.13 | 08:01 am
Partner Headlines for CLSN
- 3 Biotechs And The Feuerstein-Ratain Rule - Seeking Alpha 04.09.13 | 09:04 am
- A 2013 Diversified Bullish Portfolio In 10 Positions - Seeking Alpha 02.28.13 | 09:02 am
- After Phase III Failure, Celsion Is Still Worthless - Seeking Alpha 02.12.13 | 09:02 am
- Is Delcath The Post-Celsion Play On Liver Cancer? - Seeking Alpha 02.04.13 | 09:02 am
- Celsion Stock Blown Apart On Thermodox Phase III Data - Seeking Alpha 02.02.13 | 09:02 am
- Biotech Weekly Recap: Loads Of Bullishness, 2 Giant Rallies, And Selling - Seeking Alpha 12.02.12 | 09:12 am
- 5 Healthcare Companies With Recent Insider Buying - Seeking Alpha 11.18.12 | 09:11 am
- Pre-Market Earnings Report for November 12, 2012 : DHI, CYD, BZH, CLSN, RRST, CTIB - NASDAQ 11.09.12 | 09:11 pm
- 4 Biotechs That Just Got Mauled By Bears - Seeking Alpha 10.10.12 | 09:10 am
- Weekly CEO Buys Highlight: NIHD, RENT, VTNC, MDW - NASDAQ 09.24.12 | 02:09 pm
